JOUNCE THERAPEUTICS INC (JNCE)
US4811161011 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -50.92M | -90.87M | -43.80M | 56.80M | -27.40M | |||
| Depreciation Amortization | 2.09M | 2.83M | 3.40M | 3.90M | 3.80M | |||
| Change In Working Capital | 8.88M | -7.85M | 2.80M | -98.90M | -48.40M | |||
| Interest Paid | 4.67M | N/A | 4.00M | 4.30M | N/A | |||
| Taxes Paid | 17.00K | 8.00K | 0.00 | 100.00K | 0.00 | |||
| Other non cash items | 11.07M | 12.40M | 9.80M | 8.10M | 8.30M | |||
| OPERATING CASH FLOW | -28.88M | -83.49M | -27.80M | -30.10M | -63.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -919.00K | -373.00K | -100.00K | -1.00M | -1.40M | |||
| Other Investing Activity | 84.40M | -60.14M | 51.40M | 32.40M | 87.80M | |||
| INVESTING CASH FLOW | 83.48M | -60.51M | 51.30M | 31.40M | 86.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 442.00K | 92.04M | 70.70M | 4.10M | 1.50M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 442.00K | 92.04M | 70.70M | 4.10M | 1.50M | |||
| CHANGE IN CASH | 55.04M | -51.96M | 94.20M | 5.40M | 24.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.88M | -83.49M | -27.80M | -30.10M | -63.60M | |||
| Capital Expenditure | -919.00K | -373.00K | -100.00K | -1.00M | -1.40M | |||
| FREE CASH FLOW | -29.80M | -83.87M | -27.90M | -31.10M | -65.00M | |||
All data in USD